The Tät® app - to give more people access to evidence-based treatment of urinary incontinence
| Reference number | |
| Coordinator | eContinence AB |
| Funding from Vinnova | SEK 300 000 |
| Project duration | October 2023 - October 2024 |
| Status | Completed |
| Venture | Innovative Startups |
| Call | Innovative Impact Startups autumn 2023 |
Important results from the project
The goal of the project is to give more access to evidence-based treatment for urinary leakage with support of the app Tät, which now has had 350,000 users. We wanted to transfer the app to a new technical platform, with increased user-friendliness, the possibility of different business models and simplifications in terms of translations into other languages. This was successful and the app is now available in 9 languages in 9 different countries with increased subscribers and revenue.
Expected long term effects
Enables faster spread of the Tät app to more countries. Enables us to test different business models for other apps within the project Enables collaboration with healthcare companies.
Approach and implementation
We transferred the Tät app (medical device class I) from one technical platform to another. In connection with this, an extensive design review was done in aim to make the app even more user-friendly and clear. We also adapted the pricing to the market and introduced new tools to facilitate translations into more languages. In parallel with this work, we held several workshops together with the regulatory consultant to update our QMS and the technical documentation.